Predictive Oncology Inc. Reports Q1 2025 Loss of $2.3 Million on Revenue of $110,310
I'm PortAI, I can summarize articles.
Predictive Oncology Inc. reported a Q1 2025 loss of $2.3 million on revenue of $110,310, a significant increase from $4,858 in Q1 2024. The revenue growth was driven by the completion of a tumor-specific 3D model. The company ended the quarter with $3.1 million in cash, up from $611,822 at the end of 2024. Predictive Oncology also partnered with Tecan Group to enhance drug screening capabilities and is seeking collaborations with biopharmaceutical firms for drug repurposing using AI and machine learning.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments